179 related articles for article (PubMed ID: 27442906)
1. Extracorporeal photopheresis practice patterns: An international survey by the ASFA ECP subcommittee.
Dunbar NM; Raval JS; Johnson A; Abikoff CM; Adamski J; Cooling LL; Grossman B; Kim HC; Marques MB; Morgan S; Schmidt AE; Sloan SR; Su LL; Szczepiorkowski ZM; West FB; Wong E; Schneiderman J
J Clin Apher; 2017 Aug; 32(4):215-223. PubMed ID: 27442906
[TBL] [Abstract][Full Text] [Related]
2. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis for graft versus host disease: Identifying a clinical pathway and associated resource utilization.
Yerrabothala S; Talebian L; Klinker K; Hickman J; Hill JM; Hayes C; Lowrey C; Szczepiorkowski ZM; Meehan KR
J Clin Apher; 2018 Jun; 33(3):310-315. PubMed ID: 29193271
[TBL] [Abstract][Full Text] [Related]
4. The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low-weight children: a novel procedure.
Schneiderman J; Jacobsohn DA; Collins J; Thormann K; Kletzel M
J Clin Apher; 2010; 25(2):63-9. PubMed ID: 20301140
[TBL] [Abstract][Full Text] [Related]
5. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.
Bisaccia E; Vonderheid EC; Geskin L
Br J Dermatol; 2009 Jul; 161(1):167-9. PubMed ID: 19298276
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the CELLEX™ and UVAR-XTS™ closed-system extracorporeal photopheresis devices in the treatment of chronic graft-versus-host disease.
Whittle RM; Denney H; Chantry AD; Alfred A; Taylor PC
J Clin Apher; 2017 Dec; 32(6):462-473. PubMed ID: 28608529
[TBL] [Abstract][Full Text] [Related]
7. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.
Liu C; Shah K; Dynis M; Eby CS; Grossman BJ
Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal photopheresis in pediatric patients: Practical and technical considerations.
DeSimone RA; Schwartz J; Schneiderman J
J Clin Apher; 2017 Dec; 32(6):543-552. PubMed ID: 28304115
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
[TBL] [Abstract][Full Text] [Related]
10. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photopheresis: technique, established and novel indications.
Marques MB; Adamski J
J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
[TBL] [Abstract][Full Text] [Related]
13. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
[TBL] [Abstract][Full Text] [Related]
14. Mode of action, indications and recommendations on extracorporeal photopheresis (ECP).
Cho A; Paulitschke V; Knobler R
J Dtsch Dermatol Ges; 2023 Nov; 21(11):1369-1380. PubMed ID: 37723908
[TBL] [Abstract][Full Text] [Related]
15. Factual reflections and recommendations on extracorporeal photopheresis in pediatrics.
Sniecinski I; Seghatchian J
Transfus Apher Sci; 2017 Apr; 56(2):118-122. PubMed ID: 28392150
[TBL] [Abstract][Full Text] [Related]
16. Current clinical applications of extracorporeal photochemotherapy.
Capuano M; Sommese L; Pignalosa O; Parente D; Fabbricini R; Nicoletti GF; De Pascale MR; Schiano C; Napoli C
Ther Apher Dial; 2015 Apr; 19(2):103-10. PubMed ID: 25363837
[TBL] [Abstract][Full Text] [Related]
17. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art.
Martino M; Fedele R; Cornelio G; Moscato T; Imbalzano L; Ressa G; Massara E; Bresolin G
Expert Opin Biol Ther; 2012 Aug; 12(8):1017-30. PubMed ID: 22587646
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
20. Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients.
Taverna F; Coluccia P; Arienti F; Birolini A; Terranova L; Mazzocchi A; Rini F; Mariani L; Melani C; Ravagnani F
J Clin Apher; 2015 Jun; 30(3):162-70. PubMed ID: 25220858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]